食品伙伴網(wǎng)訊  據(jù)歐盟食品安全局（EFSA）消息，11月21日歐盟食品安全局就埃瑪菌素（emamectin）的農(nóng)藥風(fēng)險(xiǎn)評(píng)估同行評(píng)審發(fā)布了結(jié)論。

    歐盟食品安全局認(rèn)為，當(dāng)?，斁赜糜谄咸褧r(shí)，會(huì)對(duì)水生生物構(gòu)成較大的風(fēng)險(xiǎn)；埃瑪菌素還會(huì)對(duì)蜜蜂、arthropos等非靶標(biāo)生物構(gòu)成較大的風(fēng)險(xiǎn)。

    部分原文報(bào)道如下：

    Emamectin is a new active substance for which in accordance with Article 6（2） of Council Directive 91/414/EEC the Netherlands （hereinafter referred to as the 'RMS'） received an application from Syngenta Crop Protection AG for approval. Complying with Article 6（3） of Directive 91/414/EEC, the completeness of the dossier was checked by the RMS.  The European Commission recognised in principle the completeness of the dossier by Commission Decision 2007/669/EC.

    The RMS provided its initial evaluation of the dossier on emamectin in the Draft Assessment Report （DAR）， which was received by the EFSA on 6 March 2008. The peer review was initiated on 5 October 2011 by dispatching the DAR for consultation of the Member States and the applicant Syngenta Crop Protection AG.

    Following consideration of the comments received on the DAR, it was concluded that EFSA should conduct an expert consultation in the areas of mammalian toxicology, residues, fate and behaviour and ecotoxicology and EFSA should adopt a conclusion on whether emamectin can be expected to meet the conditions provided for in Article 5 of Directive 91/414/EEC, in accordance with Article 8 of Commission Regulation （EU） No 188/2011.

    原文鏈接：<http://www.efsa.europa.eu/en/efsajournal/pub/2955.htm>